Bath & Body Works (NYSE:BBWI) Price Target Raised to $25.00 at TD Cowen

Key Points

• TD Cowen raised its price target on Bath & Body Works to $25 from $20 and kept a buy rating, implying about 25% upside from the prior close.
• Despite that bullish call, analyst sentiment remains cautious overall: the broader consensus is still around Hold, with several firms recently trimming their targets.
• Bath & Body Works recently beat Q1 earnings and revenue expectations, but sales were still down year over year, and the company maintained its full-year guidance.

Bath & Body Works (NYSE:BBWI - Get Free Report) had its price objective increased by TD Cowen from $20.00 to $25.00 in a report released on Thursday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. TD Cowen's target price points to a potential upside of 25.36% from the stock's previous close.

Other equities research analysts also recently issued reports about the company. Telsey Advisory Group dropped their price objective on Bath & Body Works from $25.00 to $22.00 and set a "market perform" rating on the stock in a report on Thursday. Barclays dropped their price objective on Bath & Body Works from $25.00 to $23.00 and set an "equal weight" rating on the stock in a report on Thursday. Raymond James Financial restated a "market perform" rating on shares of Bath & Body Works in a report on Wednesday. Piper Sandler started coverage on Bath & Body Works in a research report on Friday, May 15th. They issued a "neutral" rating and a $20.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Bath & Body Works from $21.00 to $22.00 and gave the stock a "hold" rating in a research report on Tuesday, March 3rd. Three research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $21.93.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI traded up $0.49 during mid-day trading on Thursday, hitting $19.94. 1,638,062 shares of the company traded hands, compared to its average volume of 5,725,187. The firm has a market cap of $4.02 billion, a P/E ratio of 6.34, a PEG ratio of 1.76 and a beta of 1.43. Bath & Body Works has a 52-week low of $14.27 and a 52-week high of $33.96. The firm's 50 day simple moving average is $18.65 and its 200 day simple moving average is $20.24.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.29 by $0.03. The business had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.36 billion. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The company's revenue was down 3.2% on a year-over-year basis. During the same period last year, the business posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities research analysts expect that Bath & Body Works will post 2.61 EPS for the current fiscal year.

Institutional Trading of Bath & Body Works

A number of hedge funds and other institutional investors have recently modified their holdings of BBWI. Geneos Wealth Management Inc. raised its position in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after purchasing an additional 801 shares during the period. Danske Bank A S acquired a new stake in shares of Bath & Body Works during the third quarter worth $39,000. Global Retirement Partners LLC acquired a new stake in shares of Bath & Body Works during the fourth quarter worth $31,000. Activest Wealth Management acquired a new stake in shares of Bath & Body Works during the fourth quarter worth $32,000. Finally, Advisory Services Network LLC acquired a new stake in shares of Bath & Body Works during the third quarter worth $48,000. Institutional investors own 95.14% of the company's stock.

Key Stories Impacting Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Bath & Body Works beat Q1 earnings and sales expectations, with results coming in above guidance and helping drive renewed investor confidence.
• Positive Sentiment: The company reaffirmed its full-year outlook, easing fears that the business was deteriorating faster than expected.
• Positive Sentiment: Analyst and market commentary highlighted valuation support and possible growth catalysts, including expansion opportunities and dividend appeal.
• Neutral Sentiment: Brokerages remain cautious overall, with consensus still centered around a “Hold” rating after recent updates.
• Negative Sentiment: Revenue remains under pressure, with Q1 sales down year over year as Bath & Body Works continues its turnaround effort.
• Negative Sentiment: Price target cuts from Goldman Sachs and Telsey Advisory Group suggest analysts are still tempering expectations for near-term upside.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.